p53 mutations in human tumors with chimeric EWS/FLI/1 genes
The Ewing family of tumors is recurrently characterized at the molecular level by the presence of a fusion transcript between the EWS gene on chromosome 22 and either the FL‐I or ERG genes, 2 closely related members of the Ets family of transcription factors. We have investigated 12 primary human tu...
Gespeichert in:
Veröffentlicht in: | International journal of cancer 1994-05, Vol.57 (3), p.336-340 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 340 |
---|---|
container_issue | 3 |
container_start_page | 336 |
container_title | International journal of cancer |
container_volume | 57 |
creator | Hamelin, Richard Zucman, Jessica Melot, Thomas Delatre, Olivier Thomas, Gilles |
description | The Ewing family of tumors is recurrently characterized at the molecular level by the presence of a fusion transcript between the EWS gene on chromosome 22 and either the FL‐I or ERG genes, 2 closely related members of the Ets family of transcription factors. We have investigated 12 primary human tumors, II xenografts and II cell lines, which have been shown to express chimeric EWS transcripts in search of p53 mutations. Fragments of exons 5 to 8 and the corresponding consensus splice sequences were amplified by PCR and analyzed by denaturing gradient gel electrophoresis (DGGE). In 12 of 34 samples p53 mutations were detected (including 4 samples with multiple p53 mutations). The distribution of the mutations in the various samples was as follows: primary tumors 2/12; cell lines 5/11; xenografts 5/11. No correlation between the presence or absence of p53 mutations and the presence of a specific EWS chimeric transcript was observed. In addition, we observed that p53 mutations were almost always associated with a second hit (either deletion or second mutation) on the other p53 allele. © 1994 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/ijc.2910570308 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76455411</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76455411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4008-31445b840c4c2ffcd3c9ddfece34635b5c546e722d5053976d5dc73e196f3d8a3</originalsourceid><addsrcrecordid>eNqFkU1Lw0AQhhdRaq1evQl7EG9pZ7JfCZ6ktFopeFDxGLabjd2Sj5pNKP33RhrUW09zmGfeGZ4h5BphjADhxG3MOIwRhAIG0QkZIsQqgBDFKRl2AAQKmTwnF95vABAF8AEZRCijOGZDcr8VjBZtoxtXlZ66kq7bQpe0aYuq9nTnmjU1a1fY2hk6-3idzJeLCdJPW1p_Sc4ynXt71dcReZ_P3qZPwfLlcTF9WAaGA0QBQ87FKuJguAmzzKTMxGmaWWMZl0yshBFcWhWGqQDBYiVTkRrFLMYyY2mk2YjcHXK3dfXVWt8khfPG5rkubdX6REkuBEc8CqJUnINSHTg-gKauvK9tlmxrV-h6nyAkP1qTTmvyp7UbuOmT21Vh01-899j1b_u-9kbnWa1L4_wvxiFS3Uc6LD5gO5fb_ZGlyeJ5-u-Eb0A6jbY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16744077</pqid></control><display><type>article</type><title>p53 mutations in human tumors with chimeric EWS/FLI/1 genes</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Hamelin, Richard ; Zucman, Jessica ; Melot, Thomas ; Delatre, Olivier ; Thomas, Gilles</creator><creatorcontrib>Hamelin, Richard ; Zucman, Jessica ; Melot, Thomas ; Delatre, Olivier ; Thomas, Gilles</creatorcontrib><description>The Ewing family of tumors is recurrently characterized at the molecular level by the presence of a fusion transcript between the EWS gene on chromosome 22 and either the FL‐I or ERG genes, 2 closely related members of the Ets family of transcription factors. We have investigated 12 primary human tumors, II xenografts and II cell lines, which have been shown to express chimeric EWS transcripts in search of p53 mutations. Fragments of exons 5 to 8 and the corresponding consensus splice sequences were amplified by PCR and analyzed by denaturing gradient gel electrophoresis (DGGE). In 12 of 34 samples p53 mutations were detected (including 4 samples with multiple p53 mutations). The distribution of the mutations in the various samples was as follows: primary tumors 2/12; cell lines 5/11; xenografts 5/11. No correlation between the presence or absence of p53 mutations and the presence of a specific EWS chimeric transcript was observed. In addition, we observed that p53 mutations were almost always associated with a second hit (either deletion or second mutation) on the other p53 allele. © 1994 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.2910570308</identifier><identifier>PMID: 8168993</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; Base Sequence ; Biological and medical sciences ; DNA-Binding Proteins - genetics ; Genes, p53 - genetics ; Host-tumor relations. Immunology. Biological markers ; Humans ; Medical sciences ; Mice ; Mice, Nude ; Molecular Sequence Data ; Neoplasm Proteins - genetics ; Neoplasms - genetics ; Point Mutation - genetics ; Trans-Activators - genetics ; Transplantation, Heterologous ; Tumor Cells, Cultured ; Tumors</subject><ispartof>International journal of cancer, 1994-05, Vol.57 (3), p.336-340</ispartof><rights>Copyright © 1994 Wiley‐Liss, Inc., A Wiley Company</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4008-31445b840c4c2ffcd3c9ddfece34635b5c546e722d5053976d5dc73e196f3d8a3</citedby><cites>FETCH-LOGICAL-c4008-31445b840c4c2ffcd3c9ddfece34635b5c546e722d5053976d5dc73e196f3d8a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijc.2910570308$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijc.2910570308$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4087215$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8168993$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hamelin, Richard</creatorcontrib><creatorcontrib>Zucman, Jessica</creatorcontrib><creatorcontrib>Melot, Thomas</creatorcontrib><creatorcontrib>Delatre, Olivier</creatorcontrib><creatorcontrib>Thomas, Gilles</creatorcontrib><title>p53 mutations in human tumors with chimeric EWS/FLI/1 genes</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>The Ewing family of tumors is recurrently characterized at the molecular level by the presence of a fusion transcript between the EWS gene on chromosome 22 and either the FL‐I or ERG genes, 2 closely related members of the Ets family of transcription factors. We have investigated 12 primary human tumors, II xenografts and II cell lines, which have been shown to express chimeric EWS transcripts in search of p53 mutations. Fragments of exons 5 to 8 and the corresponding consensus splice sequences were amplified by PCR and analyzed by denaturing gradient gel electrophoresis (DGGE). In 12 of 34 samples p53 mutations were detected (including 4 samples with multiple p53 mutations). The distribution of the mutations in the various samples was as follows: primary tumors 2/12; cell lines 5/11; xenografts 5/11. No correlation between the presence or absence of p53 mutations and the presence of a specific EWS chimeric transcript was observed. In addition, we observed that p53 mutations were almost always associated with a second hit (either deletion or second mutation) on the other p53 allele. © 1994 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>DNA-Binding Proteins - genetics</subject><subject>Genes, p53 - genetics</subject><subject>Host-tumor relations. Immunology. Biological markers</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Molecular Sequence Data</subject><subject>Neoplasm Proteins - genetics</subject><subject>Neoplasms - genetics</subject><subject>Point Mutation - genetics</subject><subject>Trans-Activators - genetics</subject><subject>Transplantation, Heterologous</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1Lw0AQhhdRaq1evQl7EG9pZ7JfCZ6ktFopeFDxGLabjd2Sj5pNKP33RhrUW09zmGfeGZ4h5BphjADhxG3MOIwRhAIG0QkZIsQqgBDFKRl2AAQKmTwnF95vABAF8AEZRCijOGZDcr8VjBZtoxtXlZ66kq7bQpe0aYuq9nTnmjU1a1fY2hk6-3idzJeLCdJPW1p_Sc4ynXt71dcReZ_P3qZPwfLlcTF9WAaGA0QBQ87FKuJguAmzzKTMxGmaWWMZl0yshBFcWhWGqQDBYiVTkRrFLMYyY2mk2YjcHXK3dfXVWt8khfPG5rkubdX6REkuBEc8CqJUnINSHTg-gKauvK9tlmxrV-h6nyAkP1qTTmvyp7UbuOmT21Vh01-899j1b_u-9kbnWa1L4_wvxiFS3Uc6LD5gO5fb_ZGlyeJ5-u-Eb0A6jbY</recordid><startdate>19940501</startdate><enddate>19940501</enddate><creator>Hamelin, Richard</creator><creator>Zucman, Jessica</creator><creator>Melot, Thomas</creator><creator>Delatre, Olivier</creator><creator>Thomas, Gilles</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19940501</creationdate><title>p53 mutations in human tumors with chimeric EWS/FLI/1 genes</title><author>Hamelin, Richard ; Zucman, Jessica ; Melot, Thomas ; Delatre, Olivier ; Thomas, Gilles</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4008-31445b840c4c2ffcd3c9ddfece34635b5c546e722d5053976d5dc73e196f3d8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Animals</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>DNA-Binding Proteins - genetics</topic><topic>Genes, p53 - genetics</topic><topic>Host-tumor relations. Immunology. Biological markers</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Molecular Sequence Data</topic><topic>Neoplasm Proteins - genetics</topic><topic>Neoplasms - genetics</topic><topic>Point Mutation - genetics</topic><topic>Trans-Activators - genetics</topic><topic>Transplantation, Heterologous</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hamelin, Richard</creatorcontrib><creatorcontrib>Zucman, Jessica</creatorcontrib><creatorcontrib>Melot, Thomas</creatorcontrib><creatorcontrib>Delatre, Olivier</creatorcontrib><creatorcontrib>Thomas, Gilles</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hamelin, Richard</au><au>Zucman, Jessica</au><au>Melot, Thomas</au><au>Delatre, Olivier</au><au>Thomas, Gilles</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>p53 mutations in human tumors with chimeric EWS/FLI/1 genes</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>1994-05-01</date><risdate>1994</risdate><volume>57</volume><issue>3</issue><spage>336</spage><epage>340</epage><pages>336-340</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>The Ewing family of tumors is recurrently characterized at the molecular level by the presence of a fusion transcript between the EWS gene on chromosome 22 and either the FL‐I or ERG genes, 2 closely related members of the Ets family of transcription factors. We have investigated 12 primary human tumors, II xenografts and II cell lines, which have been shown to express chimeric EWS transcripts in search of p53 mutations. Fragments of exons 5 to 8 and the corresponding consensus splice sequences were amplified by PCR and analyzed by denaturing gradient gel electrophoresis (DGGE). In 12 of 34 samples p53 mutations were detected (including 4 samples with multiple p53 mutations). The distribution of the mutations in the various samples was as follows: primary tumors 2/12; cell lines 5/11; xenografts 5/11. No correlation between the presence or absence of p53 mutations and the presence of a specific EWS chimeric transcript was observed. In addition, we observed that p53 mutations were almost always associated with a second hit (either deletion or second mutation) on the other p53 allele. © 1994 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>8168993</pmid><doi>10.1002/ijc.2910570308</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0020-7136 |
ispartof | International journal of cancer, 1994-05, Vol.57 (3), p.336-340 |
issn | 0020-7136 1097-0215 |
language | eng |
recordid | cdi_proquest_miscellaneous_76455411 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Animals Base Sequence Biological and medical sciences DNA-Binding Proteins - genetics Genes, p53 - genetics Host-tumor relations. Immunology. Biological markers Humans Medical sciences Mice Mice, Nude Molecular Sequence Data Neoplasm Proteins - genetics Neoplasms - genetics Point Mutation - genetics Trans-Activators - genetics Transplantation, Heterologous Tumor Cells, Cultured Tumors |
title | p53 mutations in human tumors with chimeric EWS/FLI/1 genes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T06%3A25%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=p53%20mutations%20in%20human%20tumors%20with%20chimeric%20EWS/FLI/1%20genes&rft.jtitle=International%20journal%20of%20cancer&rft.au=Hamelin,%20Richard&rft.date=1994-05-01&rft.volume=57&rft.issue=3&rft.spage=336&rft.epage=340&rft.pages=336-340&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/ijc.2910570308&rft_dat=%3Cproquest_cross%3E76455411%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16744077&rft_id=info:pmid/8168993&rfr_iscdi=true |